3 days ago · TOKYO and BOSTON -- February 7, 2025 – Bain Capital, a leading global private investment firm, today announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation (“Tanabe Pharma”, “MTPC” or “the Company”) in a carve-out transaction from Mitsubishi Chemical Group Corporation. The investment is ...

3 days ago · Contacts. Media: For Bain Capital (North America): Charlyn Lusk / Scott Lessne Stanton [email protected] / [email protected] (646) 502-3549 / (646) 502-3569 For Bain Capital (Asia-Pacific ...

3 days ago · U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of regulatory change for Japan's ...

3 days ago · US private equity firm Bain Capital has agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit Mitsubishi Tanabe Pharma in a deal valued at approximately Y510bn ($3.3bn).

Bain Capital has agreed to acquire Mitsubishi Chemical Group’s 4188 -4.18% pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key...

3 days ago · Bain Capital has agreed to acquire Mitsubishi Chemical Group's pharmaceutical business for more than $3 billion, a deal that would allow the Japanese company to focus on its key chemical businesses.

3 days ago · Following rumblings of a private equity bidding war late last year, Bain Capital has emerged triumphant on its quest to obtain Japanese drugmaker Mitsubishi Tanabe Pharma. Bain is laying out 510 ...

3 days ago · Bain Capital said it had been in conversation with owner Mitsubishi Chemical for ... Bain Capital has placed a $3.3bn bet on a historic shift in Japan’s conservative drugs approval regime by ...

Jan 20, 2025 · Japan's Mitsubishi Chemical Group has picked U.S. investment fund Bain Capital as the preferred bidder for its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, in a deal that could value...

21 hours ago · Bain Capital, a Boston, MA-based global private investment firm, announced it has signed a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation, an Osaka, Japan-based company ...